(Press-News.org) Adding topotecan to carboplatin plus paclitaxel, the standard treatment for ovarian cancer, does not improve progression-free survival in patients and leads to greater toxicity, according to a study published online October 11 in the Journal of the National Cancer Institute.
Cisplatin plus paclitaxel, and carboplatin plus paclitaxel, are the most widely accepted first-line regimens for advanced epithelial ovarian cancer. Still, most women relapse and die from their disease. One possible solution is to add a third agent, such as topotecan, which has activity in the treatment of recurrent disease. However, combining topotecan with carboplatin plus paclitaxel as a triplet therapy is problematic because of bone marrow toxicity. So, to integrate topotecan into the standard regimen researchers tested cisplatin plus topotecan followed by carboplatin plus paclitaxel.
The phase III randomized study included 819 women aged 28-78 with newly-diagnosed stage IIB or more advanced ovarian cancer. The study was led by Paul Hoskins, M.D., of the British Columbia Cancer Agency in Vancouver and colleagues from three other groups: the NCIC Clinical Trials Group at Queen's University in Kingston, Canada, the European Organization for Research and Treatment of Cancer – Gynecologic Cancer Group, European Union, and the Grupo Espańol de Investigación en Cáncer de Ovario in Spain.
The women in the study were from Canada and Europe, and were randomly assigned to one of two study groups: the first arm received cisplatin and topotecan, followed by carboplatin and paclitaxel; the second arm received only carboplatin and paclitaxel.
The researchers found that after a median follow-up of 43 months, 650 patients had disease progression and 406 had died. The progression-free survival of patients in the first arm was 14.6 months compared to 16.2 months for those in the second arm. Furthermore, although survival data were not mature, there is no evidence to date that patients receiving topotecan had improved survival (with a median overall survival of 42.3 months for patients in the first arm, compared to 42.1 months for those in the second).
Patients in the first arm also had more toxicity than those in the second. The common side effects included gastrointestinal symptoms, myelosuppression, neurological toxicity and myalgia. Patients in the first arm had more myelotoxicity, nausea and vomiting, while patients in the second had more neurosensory effects and allergic reactions.
The authors concluded that carboplatin plus paclitaxel remains the best standard of care for epithelial ovarian cancer stage IIB or greater. They write, "The most sensible explanation for this lack of additional benefit is that the topotecan does not have sufficient cytotoxic impact on cells that are truly refractory to platins or taxanes."
Furthermore, they explain that a drug such as topotecan needs to be effective in the refractory setting—when the cancer grows during treatment—and not just in the resistant setting—when it recurs shortly after the end of treatment. They write, "Further cytotoxic drugs need to be able to convincingly kill truly refractory cells before being added to the preexisting standard drug or drugs for efficacy testing."
In an accompanying editorial, William P. McGuire, M.D., of the Weinberg Cancer Institute at Franklin Square Hospital Center, Baltimore, writes that the trial provides further confirmation of the inactivity of topotecan to treat standard ovarian cancer. He writes, "In the end, neither the dose of topotecan, sequence of drug administration, nor platinum compound used in combination made any difference."
McGuire also points to the emergence of targeted therapies to treat ovarian cancer instead of cytotoxic agents. He writes, "Clearly, the lack of any benefit from adding topotecan, gemcitabine, or pegylated liposomal doxorubicin to the platinum/taxane in the intergroup trial has signaled the need to try new approaches."
INFORMATION:
Contacts:
Article: Dr. Elizabeth Eisenhauer, NCIC Clinical Trials Group, Queens University, eeisenhauer@ctg.queensu.ca
Editorial: Nancy Thrush, Oncology Business Development Manager, nancy.thrush@medstar.net ; 443-777-6464
Note to Reporters:
The Journal of the National Cancer Institute is published by Oxford University Press and is not affiliated with the National Cancer Institute. Attribution to the Journal of the National Cancer Institute is requested in all news coverage.
Visit JNCI online at http://jnci.oxfordjournals.org and the JNCI press room at http://www.oxfordjournals.org/our_journals/jnci/press_room.html
Follow us on Twitter @JNCI_Now
Join us on Facebook: facebook.com/thejnci
END
INDIANAPOLIS – Twenty-two physical symptoms associated with cancer – symptoms often unrecognized and undertreated – are prevalent in all types of cancers regardless of whether the patient is newly diagnosed, undergoing treatment or is a cancer survivor, according to researchers from the Regenstrief Institute and the Indiana University schools of medicine and nursing.
Common symptoms include fatigue, pain, weakness, appetite loss, dry mouth, constipation, insomnia and nausea. These physical symptoms are associated with substantial functional impairment, disability and ...
CAMBRIDGE, Mass. -- Much as an anthropologist can study populations of people to learn about their physical attributes, their environs and social structures, some marine microbiologists read the genome of microbes to glean information about the microbes themselves, their environments and lifestyles.
Using a relatively new methodology called comparative population genomics, these scientists compare the entire genomes of different populations of the same microbe to see which genes are "housekeeping" or core genes essential to all populations and which are population-specific. ...
Comprehensive new guidelines from the Osteoporosis Canada aimed at preventing fragility fractures in women and men over the age of 50 are published in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj100771.pdf.
"Fragility fractures, the consequence of osteoporosis, are responsible for excess mortality, morbidity, chronic pain, institutionalization and economic costs," writes Dr. Alexandra Papaioannou, McMaster University and Hamilton Health Sciences with coauthors. "They represent 80% of all fractures in menopausal women ...
Hospital patients admitted with malnutrition or who don't eat for several days are at greater risk of a prolonged hospital stay, according to a study published in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj091977.pdf.
The study, by Italian researchers, involved 1274 adults admitted to hospital for medical or surgical treatment. Patients who were bedridden, admitted for same-day surgery or procedure, or admitted for palliative care were excluded. Fifty-two patients died in hospital and 149 patients stayed less than ...
Having a family history of breast cancer can lead some people to wonder if their risk is out of their control. However, a study of more than 85,000 postmenopausal women observed that regular physical activity, maintaining a healthy weight, and drinking less alcohol lowers breast cancer risk for women with, and without a family history of the disease.
The University of Rochester Medical Center study, published online Oct. 12, 2010, by the journal Breast Cancer Research, is good news for women who have a close relative with breast cancer and thus fear that no matter what ...
Many countries now acknowledge the need to obtain their energy supply from renewable sources such as biomass. Prof. Verstraete will explain how his team have developed a new anaerobic digestion reactor which can generate as much electricity as 25 wind turbines. These reactors use a consortium of methanogenic (methane-producing) bacteria to degrade waste and energy crops to produce biogas (a mixture of methane and carbon) which is then converted to electricity using a turbine.
We were reminded of the threat of pandemic infectious disease with the swine flu (Influenza ...
AUDIO:
Katherine A. Beals, Ph.D., R.D., F.A.C.S.M., C.S.S.D., explains the results of a research released by the University of California, Davis, and the National Center for Food Safety and Technology, Illinois...
Click here for more information.
Denver, CO., October 12, 2010 – Research just released by the University of California, Davis and the National Center for Food Safety and Technology, Illinois Institute of Technology demonstrates that people can include potatoes in ...
New laws and regulations within various countries in Europe and across the EU as a whole are preparing the ground for the advance of fee-only financial advice in Europe. The most prominent example is probably the UK where independent advisers will have to charge their clients directly by 2012. However, according to a recent report of MyPrivateBanking Research fee-only advice is also gaining ground in Germany. The independent research company surveyed 300 wealthy individuals in Germany on their needs and preferences with regard to fee-only financial advice. The results show ...
Initial feedback from both long term and new clients has been extremely favourable, with the majority of the positive input focusing on the new colours and clear branding on the site. The expanded video and audio library on the site has also been a hit with visitors, with the number of individual visitors quadrupling since the new site was unveiled.
The Almora Unlimited organisation first opened its doors as "The Rainbow Bridge" in New Zealand in 1996, and has grown over the past few years once their potential was realised. More recently, Dellaina has been focusing their ...
Kids with big dreams, here's your chance to shine. VoiceAmerica Network is searching for young talented kids ages 10 through 17 aspiring to be radio and television broadcasters. Several hosting opportunities will be filled for the new VoiceAmerica Kids Network slated to launch January 1, 2011. Auditions will be held in Tempe, Arizona at the VoiceAmerica studios on Saturday, October 16, 2010 from 9:00am to 3:00pm PST at: Regents Centre, 1900 W. University, Suite 231, Tempe, AZ 85281.
VoiceAmerica.com has partnered with KidStar Radio Network to launch the VoiceAmerica ...
